Lund, LH, Edwards, LB, Kucheryavaya, AY, Dipchand, AI, Benden, C, Christie, JD, et al. The Registry of the International Society for Heart and Lung Transplantation: Thirtieth Official Adult Heart Transplant Report-2013; Focus Theme: Age. J Heart Lung Transplant. 2013;32(10):951–64.Google Scholar

Dipchand, AI, Kirk, R, Edwards, LB, Kucheryavaya, AY, Benden, C, Christie, JD, et al. The Registry of the International Society for Heart and Lung Transplantation: Sixteenth Official Pediatric Heart Transplantation Report-2013; Focus Theme: Age. J Heart Lung Transplant. 2013;32(10):979–88.Google Scholar

Zerbe, TR, Arena, V. Diagnostic Reliability of Endomyocardial Biopsy for Assessment of Cardiac Allograft Rejection. Hum Pathol. 1988;19(11):1307–14.Google Scholar

Wagner, K, Oliver, MC, Boyle, GJ, Miller, SA, Law, YM, Pigula, F, et al. Endomyocardial Biopsy in Pediatric Heart Transplant Recipients: A Useful Exercise? (Analysis of 1,169 Biopsies). Pediatr Transplant. 2000;4(3):186–92.Google Scholar

Mehra, MR, Uber, PA, Uber, WE, Park, MH, Scott, RL. Anything but a Biopsy: Noninvasive Monitoring for Cardiac Allograft Rejection. Curr Opin Cardiol. 2002;17(2):131–6.Google Scholar

Balzer, D, Moorhead, S, Saffitz, JE, Sekarski, DR, Canter, CE. Pediatric Endomyocardial Biopsy Performed Solely with Echocardiographic Guidance. J Am Soc Echocardiogr. 1993;6(5):510–5.CrossRefGoogle ScholarPubMed

Pomerance, A, Stovin, PG. Heart Transplant Pathology: The British Experience. Journal of Clinical Pathology. 1985;38(2):146–59.CrossRefGoogle ScholarPubMed

Spiegelhalter, DJ, Stovin, PG. An Analysis of Repeated Biopsies Following Cardiac Transplantation. Statistics in Medicine. 1983;2(1):33–40.Google Scholar

Sharples, LD, Cary, NR, Large, SR, Wallwork, J. Error Rates with which Endomyocardial Biopsy Specimens Are Graded for Rejection after Cardiac Transplantation. Am J Cardiol. 1992;70(4):527–30.CrossRefGoogle ScholarPubMed

Billingham, ME, Cary, NR, Hammond, ME, Kemnitz, J, Marboe, C, McCallister, HA, et al. A Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart and Lung Rejection: Heart Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant. 1990;9(6):587–93.Google Scholar

Stewart, S, Winters, GL, Fishbein, MC, Tazelaar, HD, Kobashigawa, J, Abrams, J, et al. Revision of the 1990 Working Formulation for the Standardization of Nomenclature in the Diagnosis of Heart Rejection. J Heart Lung Transplant. 2005;24(11):1710–20.CrossRefGoogle ScholarPubMed

Wiklund, L, Suurkula, MB, Kjellstrom, C, Berglin, E. Chordal Tissue in Endomyocardial Biopsies. Scandinavian Journal of Thoracic and Cardiovascular Surgery. 1994;28(1):13–8.Google Scholar

Rodriguez, ER, International Society for H, Lung T. The Pathology of Heart Transplant Biopsy Specimens: Revisiting the 1990 ISHLT Working Formulation. J Heart Lung Transplant. 2003;22(1):3–15.Google Scholar

Reed, EF, Demetris, AJ, Hammond, E, Itescu, S, Kobashigawa, JA, Reinsmoen, NL, et al. Acute Antibody-mediated Rejection of Cardiac Transplants. J Heart Lung Transplant. 2006;25(2):153–9.Google Scholar

Berry, GJ, Angelini, A, Burke, MM, Bruneval, P, Fishbein, MC, Hammond, E, et al. The ISHLT Working Formulation for Pathologic Diagnosis of Antibody-mediated Rejection in Heart Transplantation: Evolution and Current Status (2005–2011). J Heart Lung Transplant. 2011;30(6):601–11.Google Scholar

Berry, GJ, Burke, MM, Andersen, C, Bruneval, P, Fedrigo, M, Fishbein, MC, et al. The 2013 International Society for Heart and Lung Transplantation Working Formulation for the Standardization of Nomenclature in the Pathologic Diagnosis of Antibody-mediated Rejection in Heart Transplantation. J Heart Lung Transplant. 2013;32(12):1147–62.Google Scholar

Rose, AG, Cooper, DK, Human, PA, Reichenspurner, H, Reichart, B. Histopathology of Hyperacute Rejection of the Heart: Experimental and Clinical Observations in Allografts and Xenografts. J Heart Lung Transplant. 1991;10(2):223–34.Google ScholarPubMed

Schuurman, HJ, Gmelig Meyling, FH, Wijngaard, PL, Van der Meulen, A, Slootweg, PJ, Jambroes, G. Lymphocyte Status in Endomyocardial Biopsies and Blood after Heart Transplantation. J Pathol. 1989;159(3):197–203.CrossRefGoogle ScholarPubMed

van Besouw, NM, Balk, AH, Mochtar, B, Vaessen, LM, Weimar, W. Phenotypic Analysis of Lymphocytes Infiltrating Human Cardiac Allografts during Acute Rejection and the Development of Graft Vascular Disease. Transpl Int. 1996;9 Suppl 1:S234–6.Google Scholar

Higuchi, ML, de Assis, RV, Sambiase, NV, Reis, MM, Kalil, J, Bocchi, E, et al. Usefulness of T-cell Phenotype Characterization in Endomyocardial Biopsy Fragments from Human Cardiac Allografts. J Heart Lung Transplant. 1991;10(2):235–42.Google Scholar

Ibrahim, S, Dawson, DV, Van Trigt, P, Sanfilippo, F. Differential Infiltration by CD45RO and CD45RA Subsets of T Cells Associated with Human Heart Allograft Rejection. Am J Pathol. 1993;142(6):1794–803.Google Scholar

Mues, B, Brisse, B, Steinhoff, G, Lynn, T, Hewett, T, Sorg, C, et al. Diagnostic Assessment of Macrophage Phenotypes in Cardiac Transplant Biopsies. Eur Heart J. 1991;12 Suppl D:32–5.Google Scholar

Hoshinaga, K, Mohanakumar, T, Goldman, MH, Wolfgang, TC, Szentpetery, S, Lee, HM, et al. Clinical Significance of in Situ Detection of T Lymphocyte Subsets and Monocyte/Macrophage Lineages in Heart Allografts. Transplantation. 1984;38(6):634–7.CrossRefGoogle ScholarPubMed

Gassel, AM, Hansmann, ML, Radzun, HJ, Weyand, M. Human Cardiac Allograft Rejection. Correlation of Grading with Expression of Different Monocyte/Macrophage Markers. Am J Clin Pathol. 1990;94(3):274–9.Google Scholar

Sorrentino, C, Scarinci, A, D’Antuono, T, Piccirilli, M, Di Nicola, M, Pasquale, M, et al. Endomyocardial Infiltration by B and NK Cells Foreshadows the Recurrence of Cardiac Allograft Rejection. The Journal of Pathology. 2006;209(3):400–10.Google Scholar

Takahashi, H, Ruiz, P, Ricordi, C, Delacruz, V, Miki, A, Mita, A, et al. Quantitative in Situ Analysis of FoxP3+ T Regulatory Cells on Transplant Tissue Using Laser Scanning Cytometry. Cell Transplant. 2012;21(1):113–25.CrossRefGoogle ScholarPubMed

Fyfe, B, Loh, E, Winters, GL, Couper, GS, Kartashov, AI, Schoen, FJ. Heart Transplantation-associated Perioperative Ischemic Myocardial Injury. Morphological Features and Clinical Significance. Circulation. 1996;93(6):1133–40.Google Scholar

Kottke-Marchant, K, Ratliff, NB. Endomyocardial Lymphocytic Infiltrates in Cardiac Transplant Recipients. Incidence and Characterization. Arch Pathol Lab Med. 1989;113(6):690–8.Google Scholar

Joshi, A, Masek, MA, Brown, BW Jr., Weiss, LM, Billingham, ME. “Quilty” Revisited: A 10-year Perspective. Hum Pathol. 1995;26(5):547–57.CrossRefGoogle ScholarPubMed

Luthringer, DJ, Yamashita, JT, Czer, LS, Trento, A, Fishbein, MC. Nature and Significance of Epicardial Lymphoid Infiltrates in Cardiac Allografts. J Heart Lung Transplant. 1995;14(3):537–43.Google Scholar

Tan, CD, Baldwin, WM, 3rd, Rodriguez, ER. Update on Cardiac Transplantation Pathology. Arch Pathol Lab Med. 2007;131(8):1169–91.Google Scholar

Suit, PF, Kottke-Marchant, K, Ratliff, NB, Pippenger, CE, Easely, K. Comparison of Whole-blood Cyclosporine Levels and the Frequency of Endomyocardial Lymphocytic Infiltrates (the Quilty Lesion) in Cardiac Transplantation. Transplantation. 1989;48(4):618–21.Google Scholar

Nakhleh, RE, Copenhaver, CM, Werdin, K, McDonald, K, Kubo, SH, Strickler, JG. Lack of Evidence for Involvement of Epstein-Barr Virus in the Development of the “Quilty” Lesion of Transplanted Hearts: An in Situ Hybridization Study. J Heart Lung Transplant. 1991;10(4):504–7.Google Scholar

Freimark, D, Czer, LS, Aleksic, I, Ruan, XM, Admon, D, Blanche, C, et al. Pathogenesis of Quilty Lesion in Cardiac Allografts: Relationship to Reduced Endocardial Cyclosporine A. J Heart Lung Transplant. 1995;14(6 Pt 1):1197–203.Google Scholar

Barone, JH, Fishbein, MC, Czer, LS, Blanche, C, Trento, A, Luthringer, DJ. Absence of Endocardial Lymphoid Infiltrates (Quilty Lesions) in Nonheart Transplant Recipients Treated with Cyclosporine. J Heart Lung Transplant. 1997;16(6):600–3.Google Scholar

Marboe, CC, Billingham, M, Eisen, H, Deng, MC, Baron, H, Mehra, M, et al. Nodular Endocardial Infiltrates (Quilty Lesions) Cause Significant Variability in Diagnosis of ISHLT Grade 2 and 3 A Rejection in Cardiac Allograft Recipients. J Heart Lung Transplant. 2005;24(7 Suppl):S219–26.Google Scholar

Foerster, A, Simonsen, S, Froysaker, T. Heart Transplantation in Norway. Morphological Monitoring of Cardiac Allograft Rejection. A 3-year Follow-up. APMIS. 1988;96(1):14–24.Google Scholar

Sibley, RK, Olivari, MT, Ring, WS, Bolman, RM. Endomyocardial Biopsy in the Cardiac Allograft Recipient. A Review of 570 Biopsies. Ann Surg. 1986;203(2):177–87.Google Scholar

Kemnitz, J, Cohnert, T, Schafers, HJ, Helmke, M, Wahlers, T, Herrmann, G, et al. A Classification of Cardiac Allograft Rejection. A Modification of the Classification by Billingham. Am J Surg Pathol. 1987;11(7):503–15.Google Scholar

Myles, JL, Ratliff, NB, McMahon, JT, Golding, LR, Hobbs, RE, Rincon, G, et al. Reversibility of Myocyte Injury in Moderate and Severe Acute Rejection in Cyclosporine-treated Cardiac Transplant Patients. Arch Pathol Lab Med. 1987;111(10):947–52.Google Scholar

Hammond, EH, Yowell, RL. Ultrastructural Findings in Cardiac Transplant Recipients. Ultrastruct Pathol. 1994;18(1–2):213–20.CrossRefGoogle ScholarPubMed

Hook, S, Caple, JF, McMahon, JT, Myles, JL, Ratliff, NB. Comparison of Myocardial Cell Injury in Acute Cellular Rejection versus Acute Vascular Rejection in Cyclosporine-treated Heart Transplants. J Heart Lung Transplant. 1995;14(2):351–8.Google Scholar

McMahon, JT, Ratliff, NB. Regeneration of Adult Human Myocardium after Acute Heart Transplant Rejection. J Heart Transplant. 1990;9(5):554–67.Google Scholar

Haddad, F, Deuse, T, Pham, M, Khazanie, P, Rosso, F, Luikart, H, et al. Changing Trends in Infectious Disease in Heart Transplantation. J Heart Lung Transplant. 2010;29(3):306–15.Google Scholar

Miller, LW, Naftel, DC, Bourge, RC, Kirklin, JK, Brozena, SC, Jarcho, J, et al. Infection after Heart Transplantation: A Multiinstitutional Study. Cardiac Transplant Research Database Group. J Heart Lung Transplant. 1994;13(3):381–92; discussion 93.Google Scholar

Smart, FW, Naftel, DC, Costanzo, MR, Levine, TB, Pelletier, GB, Yancy, CW Jr., et al. Risk Factors for Early, Cumulative, and Fatal Infections after Heart Transplantation: A Multiinstitutional Study. J Heart Lung Transplant. 1996;15(4):329–41.Google Scholar

Arbustini, E, Grasso, M, Diegoli, M, Percivalle, E, Grossi, P, Bramerio, M, et al. Histopathologic and Molecular Profile of Human Cytomegalovirus Infections in Patients with Heart Transplants. Am J Clin Pathol. 1992;98(2):205–13.Google ScholarPubMed

Holliman, R, Johnson, J, Savva, D, Cary, N, Wreghitt, T. Diagnosis of Toxoplasma Infection in Cardiac Transplant Recipients Using the Polymerase Chain Reaction. Journal of Clinical Pathology. 1992;45(10):931–2.Google Scholar

Wagner, FM, Reichenspurner, H, Uberfuhr, P, Weiss, M, Fingerle, V, Reichart, B. Toxoplasmosis after Heart Transplantation: Diagnosis by Endomyocardial Biopsy. J Heart Lung Transplant. 1994;13(5):916–8.Google Scholar

Drescher, J, Wagner, D, Haverich, A, Flik, J, Stachan-Kunstyr, R, Verhagen, W, et al. Nosocomial Hepatitis B Virus Infections in Cardiac Transplant Recipients Transmitted during Transvenous Endomyocardial Biopsy. The Journal of Hospital Infection. 1994;26(2):81–92.Google Scholar

Fishman, JA, Rubin, RH, Koziel, MJ, Periera, BJ. Hepatitis C Virus and Organ Transplantation. Transplantation. 1996;62(2):147–54.Google Scholar

Breinholt, JP, Moulik, M, Dreyer, WJ, Denfield, SW, Kim, JJ, Jefferies, JL, et al. Viral Epidemiologic Shift in Inflammatory Heart Disease: The Increasing Involvement of Parvovirus B19 in the Myocardium of Pediatric Cardiac Transplant Patients. J Heart Lung Transplant. 2010;29(7):739–46.CrossRefGoogle ScholarPubMed

Peters, M, Schurmann, D, Mayr, AC, Heterzer, R, Pohle, HD, Ruf, B. Immunosuppression and Mycobacteria Other than Mycobacterium Tuberculosis: Results from Patients with and without HIV Infection. Epidemiology and Infection. 1989;103(2):293–300.Google Scholar

Patel, R, Roberts, GD, Keating, MR, Paya, CV. Infections Due to Nontuberculous Mycobacteria in Kidney, Heart, and Liver Transplant Recipients. Clin Infect Dis. 1994;19(2):263–73.Google Scholar

LeMense, GP, VanBakel, AB, Crumbley, AJ, 3rd, Judson, MA. Mycobacterium Scrofulaceum Infection Presenting as Lung Nodules in a Heart Transplant Recipient. Chest. 1994;106(6):1918–20.Google Scholar

Morio, F, Treilhaud, M, Lepelletier, D, Le Pape, P, Rigal, JC, Delile, L, et al. Aspergillus Fumigatus Endocarditis of the Mitral Valve in a Heart Transplant Recipient: A Case Report. Diagn Microbiol Infect Dis. 2008;62(4):453–6.Google Scholar

Zaoutis, TE, Webber, S, Naftel, DC, Chrisant, MA, Kaufman, B, Pearce, FB, et al. Invasive Fungal Infections in Pediatric Heart Transplant Recipients: Incidence, Risk Factors, and Outcomes. Pediatr Transplant. 2011;15(5):465–9.Google Scholar

Almyroudis, NG, Sutton, DA, Linden, P, Rinaldi, MG, Fung, J, Kusne, S. Zygomycosis in Solid Organ Transplant Recipients in a Tertiary Transplant Center and Review of the Literature. Am J Transplant. 2006;6(10):2365–74.Google Scholar

Montoya, JG, Giraldo, LF, Efron, B, Stinson, EB, Gamberg, P, Hunt, S, et al. Infectious Complications among 620 Consecutive Heart Transplant Patients at Stanford University Medical Center. Clin Infect Dis. 2001;33(5):629–40.Google Scholar

Hermanns, B, Brunn, A, Schwarz, ER, Sachweh, JS, Seipelt, I, Schroder, JM, et al. Fulminant Toxoplasmosis in a Heart Transplant Recipient. Pathol Res Pract. 2001;197(3):211–5.Google Scholar

Golino, A, Duncan, JM, Zeluff, B, DePriest, J, McAllister, HA, Radovancevic, B, et al. Leishmaniasis in a Heart Transplant Patient. J Heart Lung Transplant. 1992;11(4 Pt 1):820–3.Google Scholar

Fiorelli, AI, Santos, RH, Oliveira, JL Jr., Lourenco-Filho, DD, Dias, RR, Oliveira, AS, et al. Heart Transplantation in 107 Cases of Chagas’ Disease. Transplant Proc. 2011;43(1):220–4.Google Scholar

Deen, JL, Blumberg, DA. Infectious Disease Considerations in Pediatric Organ Transplantation. Semin Pediatr Surg. 1993;2(4):218–34.Google Scholar

Braunlin, EA, Canter, CE, Olivari, MT, Ring, WS, Spray, TL, Bolman, RM, 3rd. Rejection and Infection after Pediatric Cardiac Transplantation. Ann Thorac Surg. 1990;49(3):385–90.Google Scholar

Cladellas, M, Abadal, ML, Ballester, M, Obrador, D, Crexells, C, Matias-Guiu, X, et al. Endomyocardial Diagnosis of Cardiac Lipomatosis. Catheterization and Cardiovascular Diagnosis. 1987;13(4):269–70.Google Scholar

Bonacina, E, Recalcati, F, Mangiavacchi, M, Gronda, E. Interstitial Myocardial Lipomatosis: A Morphological Study on Endomyocardial Biopsies and Diseased Hearts Surgically Removed for Heart Transplantation. Eur Heart J. 1989;10 Suppl D:100–2.Google Scholar

Gao, SZ, Chaparro, SV, Perlroth, M, Montoya, JG, Miller, JL, DiMiceli, S, et al. Post-transplantation Lymphoproliferative Disease in Heart and Heart-Lung Transplant Recipients: 30-year Experience at Stanford University. J Heart Lung Transplant. 2003;22(5):505–14.Google Scholar

Eisen, HJ, Hicks, D, Kant, JA, Montone, KT, Mull, R, Pigott, J, et al. Diagnosis of Posttransplantation Lymphoproliferative Disorder by Endomyocardial Biopsy in a Cardiac Allograft Recipient. J Heart Lung Transplant. 1994;13(2):241–5.Google Scholar

Hanasono, MM, Kamel, OW, Chang, PP, Rizeq, MN, Billingham, ME, van de Rijn, M. Detection of Epstein-Barr Virus in Cardiac Biopsies of Heart Transplant Patients with Lymphoproliferative Disorders. Transplantation. 1995;60(5):471–3.Google Scholar

Schwend, M, Tiemann, M, Kreipe, HH, Parwaresch, MR, Kraatz, EG, Herrmann, G, et al. Rapidly Growing Epstein-Barr Virus-associated Pulmonary Lymphoma after Heart Transplantation. Eur Respir J. 1994;7(3):612–6.Google Scholar

Montone, KT, Friedman, H, Hodinka, RL, Hicks, DG, Kant, JA, Tomaszewski, JE. In Situ Hybridization for Epstein-Barr Virus NotI Repeats in Posttransplant Lymphoproliferative Disorder. Mod Pathol. 1992;5(3):292–302.Google Scholar

Lager, DJ, Burgart, LJ, Slagel, DD. Epstein-Barr Virus Detection in Sequential Biopsies from Patients with a Posttransplant Lymphoproliferative Disorder. Mod Pathol. 1993;6(1):42–7.Google Scholar

Ohta, H, Fukushima, N, Ozono, K. Pediatric Post-transplant Lymphoproliferative Disorder after Cardiac Transplantation. Int J Hematol. 2009;90(2):127–36.Google Scholar

Hanto, DW, Birkenbach, M, Frizzera, G, Gajl-Peczalska, KJ, Simmons, RL, Schubach, WH. Confirmation of the Heterogeneity of Posttransplant Epstein-Barr Virus-Associated B Cell Proliferations by Immunoglobulin Gene Rearrangement Analyses. Transplantation. 1989;47(3):458–64.Google Scholar

Kemnitz, J, Cremer, J, Gebel, M, Uysal, A, Haverich, A, Georgii, A. T-cell Lymphoma after Heart Transplantation. Am J Clin Pathol. 1990;94(1):95–101.Google Scholar

Chucrallah, AE, Crow, MK, Rice, LE, Rajagopalan, S, Hudnall, SD. Multiple Myeloma after Cardiac Transplantation: An Unusual Form of Posttransplant Lymphoproliferative Disorder. Hum Pathol. 1994;25(5):541–5.Google Scholar

Fishbein, MC, Kobashigawa, J. Biopsy-negative Cardiac Transplant Rejection: Etiology, Diagnosis, and Therapy. Curr Opin Cardiol. 2004;19(2):166–9.Google Scholar

Tan, CD, Sokos, GG, Pidwell, DJ, Smedira, NG, Gonzalez-Stawinski, GV, Taylor, DO, et al. Correlation of Donor-specific Antibodies, Complement and Its Regulators with Graft Dysfunction in Cardiac Antibody-mediated Rejection. Am J Transplant. 2009;9(9):2075–84.Google Scholar

Cohnert, TR, Kemnitz, J, Haverich, A, Dralle, H. Myocardial Calcification after Orthotopic Heart Transplantation. J Heart Transplant. 1988;7(4):304–8.Google Scholar

Florence, SH, Hutton, LC, McKenzie, FN, Kostuk, WJ. Cardiac Transplantation: Postoperative Chest Radiographs. Canadian Association of Radiologists Journal = Journal l’Association canadienne des radiologistes. 1988;39(2):115–7.Google Scholar

Millane, T, Wilson, AJ, Patel, MK, Jennison, SH, Holt, DW, Murday, AJ, et al. Mitochondrial Calcium Deposition in Association with Cyclosporine Therapy and Myocardial Magnesium Depletion: A Serial Histologic Study in Heart Transplant Recipients. J Heart Lung Transplant. 1994;13(3):473–80.Google ScholarPubMed

Yankah, AC, Musci, M, Weng, Y, Loebe, M, Zurbruegg, HR, Siniawski, H, et al. Tricuspid Valve Dysfunction and Surgery after Orthotopic Cardiac Transplantation. Eur J Cardiothorac Surg. 2000;17(4):343–8.Google Scholar

Racusen, LC, Colvin, RB, Solez, K, Mihatsch, MJ, Halloran, PF, Campbell, PM, et al. Antibody-mediated Rejection Criteria – An Addition to the BANFF 97 Classification of Renal Allograft Rejection. Am J Transplant. 2003;3(6):708–14.Google Scholar

Takemoto, SK, Zeevi, A, Feng, S, Colvin, RB, Jordan, S, Kobashigawa, J, et al. National Conference to Assess Antibody-mediated Rejection in Solid Organ Transplantation. Am J Transplant. 2004;4(7):1033–41.Google Scholar

Rodriguez, ER, Skojec, DV, Tan, CD, Zachary, AA, Kasper, EK, Conte, JV, et al. Antibody-mediated Rejection in Human Cardiac Allografts: Evaluation of Immunoglobulins and Complement Activation Products C4d and C3d as Markers. Am J Transplant. 2005;5(11):2778–85.Google Scholar

Tan, CD, Rodriguez, ER. Diagnosis of Antibody-mediated Rejection in Cardiac Transplantation: A Call for Standardization. Current Opinion in Organ Transplantation. 2010.Google Scholar

Hammond, EH, Wittwer, CT, Greenwood, J, Knape, WA, Yowell, RL, Menlove, RL, et al. Relationship of OKT3 Sensitization and Vascular Rejection in Cardiac Transplant Patients Receiving OKT3 Rejection Prophylaxis. Transplantation. 1990;50(5):776–82.Google Scholar

Bishay, ES, Cook, DJ, Starling, RC, Ratliff, NB Jr., White, J, Blackstone, EH, et al. The Clinical Significance of Flow Cytometry Crossmatching in Heart Transplantation. Eur J Cardiothorac Surg. 2000;17(4):362–9.Google Scholar

Michaels, PJ, Espejo, ML, Kobashigawa, J, Alejos, JC, Burch, C, Takemoto, S, et al. Humoral Rejection in Cardiac Transplantation: Risk Factors, Hemodynamic Consequences and Relationship to Transplant Coronary Artery Disease. J Heart Lung Transplant. 2003;22(1):58–69.Google Scholar

Taylor, DO, Yowell, RL, Kfoury, AG, Hammond, EH, Renlund, DG. Allograft Coronary Artery Disease: Clinical Correlations with Circulating Anti-HLA Antibodies and the Immunohistopathologic Pattern of Vascular Rejection. J Heart Lung Transplant. 2000;19(6):518–21.Google Scholar

Hammond, ME, Stehlik, J, Snow, G, Renlund, DG, Seaman, J, Dabbas, B, et al. Utility of Histologic Parameters in Screening for Antibody-mediated Rejection of the Cardiac Allograft: A Study of 3,170 Biopsies. J Heart Lung Transplant. 2005;24(12):2015–21.Google Scholar

Bonnaud, EN, Lewis, NP, Masek, MA, Billingham, ME. Reliability and Usefulness of Immunofluorescence in Heart Transplantation. J Heart Lung Transplant. 1995;14(1 Pt 1):163–71.Google Scholar

Kucirka, LM, Maleszewski, JJ, Segev, DL, Halushka, MK. Survey of North American Pathologist Practices Regarding Antibody-mediated Rejection in Cardiac Transplant Biopsies. Cardiovasc Pathol. 2011;20(3):132–8.CrossRefGoogle ScholarPubMed

Revelo, MP, Stehlik, J, Miller, D, Snow, GL, Everitt, MD, Budge, D, et al. Antibody Testing for Cardiac Antibody-mediated Rejection: Which Panel Correlates Best with Cardiovascular Death? J Heart Lung Transplant. 2011;30(2):144–50.CrossRefGoogle ScholarPubMed

Rodriguez, ER, Tan, CD. Pathologic Evaluation for Antibody-mediated Rejection: Prognostic vs Diagnostic Markers? The Journal of Heart and Lung Transplantation: The Official Publication of the International Society for Heart Transplantation. 2011;30(2):136–8.Google Scholar

Baldwin, WM, Ota, H, Rodriguez, ER. Complement in Transplant Rejection: Diagnostic and Mechanistic Considerations. Springer Semin Immunopathol. 2003;25(2):181–97.Google Scholar

Baldwin, WM, 3rd, Kasper, EK, Zachary, AA, Wasowska, BA, Rodriguez, ER. Beyond C4d: Other Complement-related Diagnostic Approaches to Antibody-mediated Rejection. Am J Transplant. 2004;4(3):311–8.Google Scholar

Berry, GJ, Burke, MM, Anderson, C, Bruneval, P, Fedrigo, M, Fishbein, MC, et al. Isht Consensus Statement: International Society for Heart and Lung Transplantation 2013 Working Formulation for the Standardization of Nomenclature in the Pathologic Diagnosis of Antibody-mediated Rejection in Heart Transplantation. J Heart Lung Transplant. 2013;in press.Google Scholar

Miller, DV, Everitt, MD, Molina, KM, Alharethi, R, Budge, D, Wachter, B, et al. Clinical and Prognostic Significance of C3d and C4d Positive Immunopathology Pattern Versus C4d Positive Alone. Journal of Heart and Lung Transplantation. 2013;32(4):S20–S.Google Scholar

Rodriguez, R, Moses, JE, Adlington, RM, Baldwin, JE. A New and Efficient Method for O-quinone Methide Intermediate Generation: Application to the Biomimetic Synthesis of the Benzopyran Derived Natural Products (+/-)-Lucidene and (+/-)-Alboatrin. Organic & Biomolecular Chemistry. 2005;3(19):3488–95.Google Scholar

Baldwin, WM, 3rd, Samaniego-Picota, M, Kasper, EK, Clark, AM, Czader, M, Rohde, C, et al. Complement Deposition in Early Cardiac Transplant Biopsies Is Associated with Ischemic Injury and Subsequent Rejection Episodes. Transplantation. 1999;68(6):894–900.Google Scholar

Hammond, EH, Yowell, RL, Nunoda, S, Menlove, RL, Renlund, DG, Bristow, MR, et al. Vascular (Humoral) Rejection in Heart Transplantation: Pathologic Observations and Clinical Implications. J Heart Transplant. 1989;8(6):430–43.Google Scholar

Lones, MA, Czer, LS, Trento, A, Harasty, D, Miller, JM, Fishbein, MC. Clinical-pathologic Features of Humoral Rejection in Cardiac Allografts: A Study in 81 Consecutive Patients. J Heart Lung Transplant. 1995;14(1 Pt 1):151–62.Google ScholarPubMed

Loupy, A, Cazes, A, Guillemain, R, Amrein, C, Hedjoudje, A, Tible, M, et al. Very Late Heart Transplant Rejection Is Associated with Microvascular Injury, Complement Deposition and Progression to Cardiac Allograft Vasculopathy. Am J Transplant. 2011;11(7):1478–87.Google Scholar

Mollnes, TE. Complement and Biocompatibility. Vox Sang. 1998;74 Suppl 2:303–7.Google Scholar

Mollnes, TE. Biocompatibility: Complement as Mediator of Tissue Damage and as Indicator of Incompatibility. Experimental and Clinical Immunogenetics. 1997;14(1):24–9.Google Scholar

Williams, JM, Holzknecht, ZE, Plummer, TB, Lin, SS, Brunn, GJ, Platt, JL. Acute Vascular Rejection and Accommodation: Divergent Outcomes of the Humoral Response to Organ Transplantation. Transplantation. 2004;78(10):1471–8.Google Scholar

Haas, M, Rahman, MH, Racusen, LC, Kraus, ES, Bagnasco, SM, Segev, DL, et al. C4d and C3d Staining in Biopsies of ABO- and HLA-incompatible Renal Allografts: Correlation with Histologic Findings. Am J Transplant. 2006;6(8):1829–40.Google Scholar

Kirschfink, M. Targeting Complement in Therapy. Immunol Rev. 2001;180:177–89.Google Scholar

Kim, DD, Song, WC. Membrane Complement Regulatory Proteins. Clinical Immunology (Orlando, Fla). 2006;118(2–3):127–36.Google Scholar

Gonzalez-Stawinski, GV, Tan, CD, Smedira, NG, Starling, RC, Rodriguez, ER. Decay-accelerating Factor Expression May Provide Immunoprotection against Antibody-mediated Cardiac Allograft Rejection. J Heart Lung Transplant. 2008;27(4):357–61.Google Scholar

Wehner, J, Morrell, CN, Reynolds, T, Rodriguez, ER, Baldwin, WM, 3rd. Antibody and Complement in Transplant Vasculopathy. Circ Res. 2007;100(2):191–203.CrossRefGoogle ScholarPubMed

Kuo, HH, Morrell, CN, Baldwin, WM, 3rd. Alloantibody Induced Platelet Responses in Transplants: Potent Mediators in Small Packages. Hum Immunol. 2012.CrossRefGoogle Scholar

Labarrere, CA, Woods, JR, Hardin, JW, Campana, GL, Ortiz, MA, Jaeger, BR, et al. Early Prediction of Cardiac Allograft Vasculopathy and Heart Transplant Failure. Am J Transplant. 2011;11(3):528–35.Google Scholar

Libby, P, Pober, JS. Chronic Rejection. Immunity. 2001;14(4):387–97.CrossRefGoogle ScholarPubMed

Tuzcu, EM, Hobbs, RE, Rincon, G, Bott-Silverman, C, De Franco, AC, Robinson, K, et al. Occult and Frequent Transmission of Atherosclerotic Coronary Disease with Cardiac Transplantation. Insights from Intravascular Ultrasound. Circulation. 1995;91(6):1706–13.Google Scholar

Gaudin, PB, Rayburn, BK, Hutchins, GM, Kasper, EK, Baughman, KL, Goodman, SN, et al. Peritransplant Injury to the Myocardium Associated with the Development of Accelerated Arteriosclerosis in Heart Transplant Recipients. Am J Surg Pathol. 1994;18(4):338–46.Google Scholar

Koskinen, P, Lemstrom, K, Bruggeman, C, Lautenschlager, I, Hayry, P. Acute Cytomegalovirus Infection Induces a Subendothelial Inflammation (Endothelialitis) in the Allograft Vascular Wall. A Possible Linkage with Enhanced Allograft Arteriosclerosis. Am J Pathol. 1994;144(1):41–50.Google Scholar

Hosenpud, JD, Morris, TE, Shipley, GD, Mauck, KA, Wagner, CR. Cardiac Allograft Vasculopathy. Preferential Regulation of Endothelial Cell-derived Mesenchymal Growth Factors in Response to a Donor-specific Cell-mediated Allogeneic Response. Transplantation. 1996;61(6):939–48.Google Scholar

Petrossian, GA, Nichols, AB, Marboe, CC, Sciacca, R, Rose, EA, Smith, CR, et al. Relation between Survival and Development of Coronary Artery Disease and Anti-HLA Antibodies after Cardiac Transplantation. Circulation. 1989;80(5 Pt 2):III122–5.Google Scholar

Smith, SH, Kirklin, JK, Geer, JC, Caulfield, JB, McGiffin, DC. Arteritis in Cardiac Rejection after Transplantation. Am J Cardiol. 1987;59(12):1171–3.Google Scholar

Foerster, A. Vascular Rejection in Cardiac Transplantation. A Morphological Study of 25 Human Cardiac Allografts. APMIS. 1992;100(4):367–76.Google Scholar

Hengstenberg, C, Hufnagel, G, Haverich, A, Olsen, EG, Maisch, B. De Novo Expression of MHC Class I and Class II Antigens on Endomyocardial Biopsies from Patients with Inflammatory Heart Disease and Rejection Following Heart Transplantation. Eur Heart J. 1993;14(6):758–63.Google Scholar

Hosenpud, JD, Everett, JP, Morris, TE, Mauck, KA, Shipley, GD, Wagner, CR. Cardiac Allograft Vasculopathy. Association with Cell-mediated but Not Humoral Alloimmunity to Donor-specific Vascular Endothelium. Circulation. 1995;92(2):205–11.Google Scholar

Duquesnoy, RJ, Kaufman, C, Zerbe, TR, Woan, MC, Zeevi, A. Presence of CD4, CD8 Double-negative and T-cell Receptor-Gamma-Delta-positive T Cells in Lymphocyte Cultures Propagated from Coronary Arteries from Heart Transplant Patients with Graft Coronary Disease. J Heart Lung Transplant. 1992;11(3 Pt 2):S83–6.Google Scholar

Faulk, WP, Labarrere, CA, Nelson, DR, Pitts, D. Coronary Artery Disease in Cardiac Allografts: Association with Arterial Antithrombin. Transplant Proc. 1995;27(3):1944–6.Google Scholar

Labarrere, CA, Pitts, D, Nelson, DR, Faulk, WP. Coronary Artery Disease in Cardiac Allografts: Association with Depleted Arteriolar Tissue Plasminogen Activator. Transplant Proc. 1995;27(3):1941–3.Google Scholar

Koskinen, PK. The Association of the Induction of Vascular Cell Adhesion Molecule-1 with Cytomegalovirus Antigenemia in Human Heart Allografts. Transplantation. 1993;56(5):1103–8.Google Scholar

Dong, C, Redenbach, D, Wood, S, Battistini, B, Wilson, JE, McManus, BM. The Pathogenesis of Cardiac Allograft Vasculopathy. Curr Opin Cardiol. 1996;11(2):183–90.Google Scholar

Herrington, DM, Nanjee, N, Achuff, SC, Cameron, DE, Dobbs, B, Baughman, KL. Dehydroepiandrosterone and Cardiac Allograft Vasculopathy. J Heart Lung Transplant. 1996;15(1 Pt 1):88–93.Google Scholar

Denfield, SW. Cardiac Transplant Coronary Allograft Vasculopathy in Children: Achilles’ Heel. Congenital Heart Disease. 2012;7(4):301.Google Scholar

Jeewa, A, Dreyer, WJ, Kearney, DL, Denfield, SW. The Presentation and Diagnosis of Coronary Allograft Vasculopathy in Pediatric Heart Transplant Recipients. Congenital heart disease. 2012;7(4):302–11.Google Scholar

Billingham, ME. Histopathology of Graft Coronary Disease. J Heart Lung Transplant. 1992;11(3 Pt 2):S38–44.Google Scholar

Pucci, AM, Forbes, RD, Billingham, ME. Pathologic Features in Long-term Cardiac Allografts. J Heart Transplant. 1990;9(4):339–45.Google Scholar

Berry, GJ, Rizeq, MN, Weiss, LM, Billingham, ME. Graft Coronary Disease in Pediatric Heart and Combined Heart-Lung Transplant Recipients: A Study of Fifteen Cases. J Heart Lung Transplant. 1993;12(6 Pt 2):S309–19.Google Scholar

Clausell, N, Butany, J, Molossi, S, Lonn, E, Gladstone, P, Rabinovitch, M, et al. Abnormalities in Intramyocardial Arteries Detected in Cardiac Transplant Biopsy Specimens and Lack of Correlation with Abnormal Intracoronary Ultrasound or Endothelial Dysfunction in Large Epicardial Coronary Arteries. J Am Coll Cardiol. 1995;26(1):110–9.Google Scholar

Luk, A, Ahn, E, Lee, A, Ross, HJ, Butany, J. Recurrent Cardiac Amyloidosis Following Previous Heart Transplantation. Cardiovasc Pathol. 2010;19(4):e129–33.Google Scholar

Caines, AE, Kpodonu, J, Massad, MG, Chaer, R, Evans, A, Lee, JC, et al. Cardiac Transplantation in Patients with Iron Overload Cardiomyopathy. J Heart Lung Transplant. 2005;24(4):486–8.Google Scholar

Kuppahally, SS, Hunt, SA, Valantine, HA, Berry, GJ. Recurrence of Iron Deposition in the Cardiac Allograft in a Patient with Non-HFE Hemochromatosis. J Heart Lung Transplant. 2006;25(1):144–7.Google Scholar

Scott, RL, Ratliff, NB, Starling, RC, Young, JB. Recurrence of Giant Cell Myocarditis in Cardiac Allograft. J Heart Lung Transplant. 2001;20(3):375–80.Google Scholar

Chung, L, Berry, GJ, Chakravarty, EF. Giant Cell Myocarditis: A Rare Cardiovascular Manifestation in a Patient with Systemic Lupus Erythematosus. Lupus. 2005;14(2):166–9.Google Scholar

Kong, G, Madden, B, Spyrou, N, Pomerance, A, Mitchell, A, Yacoub, M. Response of Recurrent Giant Cell Myocarditis in a Transplanted Heart to Intensive Immunosuppression. Eur Heart J. 1991;12(4):554–7.Google Scholar

Strecker, T, Zimmermann, I, Wiest, GH. [Pulmonary and Cardiac Recurrence of Sarcoidosis in a Heart Transplant Recipient]. Dtsch Med Wochenschr. 2007;132(21):1159–62.Google Scholar

Luk, A, Lee, A, Ahn, E, Soor, GS, Ross, HJ, Butany, J. Cardiac Sarcoidosis: Recurrent Disease in a Heart Transplant Patient Following Pulmonary Tuberculosis Infection. Can J Cardiol. 2010;26(7):e273–5.Google Scholar

Schwarz, ER, Czer, LS, Simsir, SA, Kass, RM, Trento, A. Amiodarone-induced QT Prolongation in a Newly Transplanted Heart Associated with Recurrent Ventricular Fibrillation. Cardiovascular Journal of Africa. 2010;21(2):109–12.Google Scholar

Miriuka, SG, Langman, LJ, Evrovski, J, Miner, SE, Kozuszko, S, D’Mello, N, et al. Thromboembolism in Heart Transplantation: Role of Prothrombin G20210A and Factor V Leiden. Transplantation. 2005;80(5):590–4.Google Scholar

Mullen, JC, Lemermeyer, G, Bentley, MJ. Recurrent Aortic Dissection after Orthotopic Heart Transplantation. Ann Thorac Surg. 1996;62(6):1830–1.Google Scholar

Hollander, SA, Yasnovsky, JR, Reinhartz, O, Chan, F, Sandborg, C, Hunt, S, et al. Behcet’s Disease and Heart Transplantation: A Word of Caution. J Heart Lung Transplant. 2010;29(11):1306–8.Google Scholar

Akhter, SA, McGinty, J, Konys, JJ, Giesting, RM, Merrill, WH, Wagoner, LE. Recurrent Primary Cardiac Malignant Fibrous Histiocytoma Following Orthotopic Heart Transplantation. J Heart Lung Transplant. 2004;23(12):1447–50.Google Scholar

Myruski, KS, Manecke, GR Jr., Kotzur, A, Wahrenbrock, EA, Jamieson, SW. Late Recurrence of Cardiac Sarcoma Presenting as Giant Pulmonary Artery Aneurysm. J Heart Lung Transplant. 2004;23(12):1445–6.Google Scholar

Bonatti, H, Hoefer, D, Rogatsch, H, Margreiter, R, Larcher, C, Antretter, H. Successful Management of Recurrent Epstein-Barr Virus-associated Multilocular Leiomyosarcoma after Cardiac Transplantation. Transplant Proc. 2005;37(4):1839–44.Google Scholar